港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

中醫藥概念

685.790

-4.792-0.69%

漲家數：6

跌家數：2

平家數：3

市盈率：- -

高：689.685

開：686.569

低：681.262

收：690.582

資料載入中...

【康臣藥業(01681.HK)：益腎化濕顆粒獲批准為中藥二級保護品種】康臣藥業(01681.HK)發佈公告，於2025年4月28日，國家藥品監督管理局發佈《中藥保護品種公告(第25號 )( 2025年第45號)》，其中載列集團的產品益腎化濕顆粒(該產品)已根據《中藥品種保護條例》獲批准為中藥二級保護品種，公司的全資附屬公司廣州康臣藥業有限公司(廣州康臣)獲頒《中藥保護品種證書》(該證書)，證書號：(2025)國藥中保證字第009號。

康臣藥業(01681.HK)益腎化濕顆粒獲批中藥二級保護品種

阿斯达克财经

康臣藥業(01681)：益腎化濕顆粒獲批准為中藥二級保護品種

康臣藥業04月30日主力淨流出160.9萬元散户資金買入

中國中藥04月30日獲主力加倉431.3萬元

綠葉製藥(02186)出現大手賣出82.35萬股，成交價$2.02，涉資166.347萬

阿斯达克财经

LuYe Pharmaceutical Investment Co., Ltd.增持綠葉製藥200萬股每股作價1.99港元

同仁堂國藥將於6月18日派發末期股息每股0.35港元

白雲山擬委任程洪進和唐和平為執行董事

白雲山(00874)：注射用頭孢噻肟鈉(0.5g、1.0g)通過仿製藥一致性評價

白雲山(00874)建議委任程洪進和唐和平為第九屆董事會執行董事

智通财经网

白雲山(00874)：廣州醫藥獲准於全國中小企業股份轉讓系統掛牌

同仁堂國藥(03613)將於6月18日派發末期股息每股0.35港元

同仁堂科技(01666.HK)首季純利錄2.27億人民幣

阿斯达克财经

同仁堂科技一季度歸母淨利2.27億元

現代中藥集團(01643)股價下跌9.211%，現價港幣$0.345

阿斯达克财经

現代中藥集團盤中異動股價大跌5.26%報0.360港元

每日賣空追蹤 | 白雲山 04月25日賣空量成交2.4萬股，賣空比例為6.78%

康臣藥業：收到SK-09片臨牀試驗批准通知書

康臣藥業(01681.HK)治療腎臟疾病藥物於中國獲批開展臨牀試驗

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1606/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"中醫藥概念","latestPrice":685.79004,"timestamp":1746000495771,"preClose":690.58167,"halted":0,"volume":43601948,"delay":0,"changeRate":-0.006939,"floatShares":0,"shares":0,"eps":0,"marketStatus":"勞動節休市","change":-4.791626,"latestTime":"04-30 16:00:00","open":686.56903,"high":689.68536,"low":681.2621,"amount":141992223,"amplitude":0.012197,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"pbRate":0.871958,"peRate":13.295618,"turnoverRate":0.002774,"increases":3,"decrements":3,"flats":5,"marketCap":75085783760,"floatMarketCap":48266577872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":689.68536,"amplitude":0.012197,"preClose":690.58167,"low":681.2621,"pbRate":"0.871958","latestPrice":685.79004,"volume":43601948,"delay":0,"open":686.56903,"prevYearClose":739.0471,"prevWeekClose":697.342,"prevMonthClose":689.055,"prevQuarterClose":689.055,"fiveDayClose":701.147,"twentyDayClose":718.463,"sixtyDayClose":675.957,"secType":"PLATE","market":"HK","turnoverRate":0.002774,"peRate":13.295618,"marketCap":75085783760,"floatMarketCap":48266577872,"timestamp":1746000495771,"nameCN":"中醫藥概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":6,"down":2,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531707864","title":"【康臣藥業(01681.HK)：益腎化濕顆粒獲批准為中藥二級保護品種】康臣藥業(01681.HK)發佈公告，於2025年4月28日，國家藥品監督管理局發佈《中藥保護品種公告(第25號 )( 2025年第45號)》，其中載列集團的產品益腎化濕顆粒(該產品)已根據《中藥品種保護條例》獲批准為中藥二級保護品種，公司的全資附屬公司廣州康臣藥業有限公司(廣州康臣)獲頒《中藥保護品種證書》(該證書)，證書號：(2025)國藥中保證字第009號。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531707864","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531707864?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 16:58","pubTimestamp":1746003489,"startTime":"0","endTime":"0","summary":"康臣药业(01681.HK)发布公告，于2025年4月28日，国家药品监督管理局发布《中药保护品种公告(第25号 )( 2025年第45号)》，其中载列集团的产品益肾化湿颗粒(该产品)已根据《中药品种保护条例》获批准为中药二级保护品种，公司的全资附属公司广州康臣药业有限公司(广州康臣)获颁《中药保护品种证书》(该证书)，证书号：(2025)国药中保证字第009号。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30165850045162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2531707006","title":"康臣藥業(01681.HK)益腎化濕顆粒獲批中藥二級保護品種","url":"https://stock-news.laohu8.com/highlight/detail?id=2531707006","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531707006?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 16:56","pubTimestamp":1746003360,"startTime":"0","endTime":"0","summary":"康臣药业(01681.HK) 公布，国家药品监督管理局于4月28日发布《中药保护品种公告(第25号)(2025年第45号)》，其中载列公司旗下产品“益肾化湿颗粒”已根据《中药品种保护条例》，获批准为中药二级保护品种，全资附属公司广州康臣药业获颁《中药保护品种证书》，该产品将享有7年国家保护期，并可于进一步申请时重续。康臣药业表示，于保护期内其他企业不得仿制该产品，预料将有利于未来长期发展。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-30 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220720140432583_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220720140432583_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1437198/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2531702400","title":"康臣藥業(01681)：益腎化濕顆粒獲批准為中藥二級保護品種","url":"https://stock-news.laohu8.com/highlight/detail?id=2531702400","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531702400?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 16:54","pubTimestamp":1746003276,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2025年4月28日，国家药品监督管理局发布《中药保护品种公告(第25号 )( 2025年第45号)》，其中载列集团的产品益肾化湿颗粒(该产品)已根据《中药品种保护条例》获批准为中药二级保护品种，公司的全资附属公司广州康臣药业有限公司(广州康臣)获颁《中药保护品种证书》(该证书)，证书号：(2025)国药中保证字第009号。该产品享有7年国家保护期，并可于进一步申请时重续。于保护期内，其他企业不得仿制该产品。于本公告日期，广州康臣为该产品及该证书的唯一持有人。董事会认为，有关认可是国家对该产品的支持，将有利于集团未来的长期发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)：益肾化湿颗粒获批准为中药二级保护品种","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2531085158","title":"康臣藥業04月30日主力淨流出160.9萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531085158?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000946,"startTime":"0","endTime":"0","summary":"04月30日, 康臣药业股价跌2.53%，报收9.26元，成交金额1729.2万元，换手率0.22%，振幅3.37%，量比1.15。康臣药业今日主力资金净流出160.9万元，上一交易日主力净流入31.1万元。该股近5个交易日下跌5.24%，主力资金累计净流出171.4万元；近20日主力资金累计净流入1829.1万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171226a6ce9ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171226a6ce9ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2531084183","title":"中國中藥04月30日獲主力加倉431.3萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531084183","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531084183?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000913,"startTime":"0","endTime":"0","summary":"04月30日, 中国中药股价涨0.50%，报收2.02元，成交金额4121.3万元，换手率0.41%，振幅1.49%，量比0.99。中国中药今日主力资金净流入431.3万元，连续7日净流入，上一交易日主力净流入305.6万元。该股近5个交易日下跌0.98%，主力资金累计净流入2039.6万元；近20日主力资金累计净流入8427.5万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170246a46d725c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170246a46d725c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00570","BK1515","BK1606","BK1191"],"gpt_icon":0},{"id":"2531704380","title":"綠葉製藥(02186)出現大手賣出82.35萬股，成交價$2.02，涉資166.347萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2531704380","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531704380?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 16:08","pubTimestamp":1746000480,"startTime":"0","endTime":"0","summary":"[大手成交]绿叶制药(02186)在下午04:08出现大手卖出，成交量为82.35万，成交价为港币$2.02，涉资166.347万。至目前为止，股价升0.498%，今日最高价为$2.03，而最低价为$2.0，总成交量为1.51千万股，总成交金额港币$3.038千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2504308029/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02186","BK1583","BK1606","BK1191"],"gpt_icon":0},{"id":"2531730163","title":"LuYe Pharmaceutical Investment Co., Ltd.增持綠葉製藥200萬股 每股作價1.99港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531730163","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531730163?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 21:11","pubTimestamp":1745932305,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月28日，LuYe Pharmaceutical Investment Co., Ltd.增持绿叶制药(02186)200万股，每股作价1.99港元，总金额为398万港元。增持后最新持股数目约12.46亿股，最新持股比例为33.13%。本交易涉及其他关联方：LuYe Pharmaceutical International Co., Ltd.、Luye Pharma Holdings Ltd.、Nelumbo Investments Limited和Luye Life Sciences Group Ltd。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429212704974a37e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429212704974a37e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02186","BK1583","BK1606"],"gpt_icon":0},{"id":"2531005992","title":"同仁堂國藥將於6月18日派發末期股息每股0.35港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531005992","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531005992?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 18:07","pubTimestamp":1745921220,"startTime":"0","endTime":"0","summary":"同仁堂国药(03613)发布公告，将于2025年6月18日派发截至2024年12月...同仁堂国药(03613)发布公告，将于2025年6月18日派发截至2024年12月31日止年度的末期股息每股0.35港元。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181057a46bea00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181057a46bea00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03613","BK1191","BK1606"],"gpt_icon":0},{"id":"2531678846","title":"白雲山擬委任程洪進和唐和平為執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2531678846","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531678846?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 18:06","pubTimestamp":1745921166,"startTime":"0","endTime":"0","summary":"格隆汇4月29日丨白云山(00874.HK)公告，董事会建议委任程洪进和唐和平为公司第九届董事会执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918064294e75af7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918064294e75af7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00874","BK1197","BK1515","BK1191","BK1606","BK1521"],"gpt_icon":0},{"id":"2531043662","title":"白雲山(00874)：注射用頭孢噻肟鈉(0.5g、1.0g)通過仿製藥一致性評價","url":"https://stock-news.laohu8.com/highlight/detail?id=2531043662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531043662?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 17:52","pubTimestamp":1745920354,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，近日，公司控股子公司广州白云山天心制药股份有限公司(简称“天心药业”)收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，注射用头孢噻肟钠(0.5g、1.0g)已通过仿制药质量和疗效一致性评价。注射用头孢噻肟钠为第三代头孢菌素抗生素，适用于敏感菌所致的下呼吸道感染、泌尿生殖道感染、妇科感染、菌血症/败血症、皮肤及皮肤软组织感染、腹腔感染、骨和关节感染、中枢神经系统感染。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0097","BK0175","BK0028","BK1521","BK0070","BK1606","BK0183","BK0096","BK0188","BK0196","BK1191","BK1197","BK0239","00874","BK0012","BK1515","600332"],"gpt_icon":0},{"id":"2531754201","title":"白雲山(00874)建議委任程洪進和唐和平為第九屆董事會執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2531754201","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531754201?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 17:44","pubTimestamp":1745919883,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，董事会建议委任程洪进和唐和平为公司第九届董事会执行董事。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1197","BK1606","00874","BK0097","BK0188","BK0070","BK0239","BK0012","BK1191","BK0028","BK0183","600332","BK0196","BK0175","BK1515","BK0096","BK1521"],"gpt_icon":0},{"id":"2531011732","title":"白雲山(00874)：廣州醫藥獲准於全國中小企業股份轉讓系統掛牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2531011732","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531011732?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 17:42","pubTimestamp":1745919756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，该公司附属广州医药于2025年4月29日收到全国股转公司出具的《关于同意广州医药股份有限公司股票公开转让并在全国股转系统挂牌的函》，同意广州医药股票公开转让并在全国中小企业股份转让系统挂牌，交易方式为集合竞价交易。广州医药申请公开转让并挂牌时股东人数未超过200人，按规定中国证监会豁免注册，广州医药挂牌后纳入非上市公众公司监管。广州医药将按照有关规定办理挂牌、报备等手续。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0097","BK1515","BK0196","BK0070","159938","BK1197","00874","BK1161","BK1521","BK1606","BK0096","BK0012","BK1574","BK1191","BK0188","600332","09939","BK0183","BK0028","BK0239","BK0175"],"gpt_icon":0},{"id":"2531076277","title":"同仁堂國藥(03613)將於6月18日派發末期股息每股0.35港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531076277","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531076277?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 16:59","pubTimestamp":1745917190,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同仁堂国药(03613)发布公告，将于2025年6月18日派发截至2024年12月31日止年度的末期股息每股0.35港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"同仁堂国药(03613)将于6月18日派发末期股息每股0.35港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","03613","BK1191"],"gpt_icon":0},{"id":"2530342214","title":"同仁堂科技(01666.HK)首季純利錄2.27億人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2530342214","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530342214?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 17:31","pubTimestamp":1745832660,"startTime":"0","endTime":"0","summary":"同仁堂科技(01666.HK) 公布，根据中国企业会计准则，截至今年3月31日止季度公司及其附属公司录未经审计营业收入约20.35亿元人民币，净利润约2.27亿元人民币。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-28 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180411174158999_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180411174158999_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1436446&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","01666","BK1606","BK1191","BK1583"],"gpt_icon":0},{"id":"2530424943","title":"同仁堂科技一季度歸母淨利2.27億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530424943","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530424943?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 16:51","pubTimestamp":1745830297,"startTime":"0","endTime":"0","summary":"为保证公司全体股东公平、及时地知晓公司信息，公司特此公布以下财务信息：根据中华人民共和国财政部颁布的《中华人民共和国企业会计准则》，截至2025年3月31日止3个月，集团未经审计营业收入约人民币203,542万元，未经审计营业成本约人民币113,994万元，及未经审计归属于母公司所有者的净利润约人民币22,723万元。于2025年3月31日止，集团未经审计总资产约人民币1,459,380万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428165148974838eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428165148974838eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","BK1606","01666","BK1191"],"gpt_icon":0},{"id":"2530450604","title":"現代中藥集團(01643)股價下跌9.211%，現價港幣$0.345","url":"https://stock-news.laohu8.com/highlight/detail?id=2530450604","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530450604?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 14:35","pubTimestamp":1745822100,"startTime":"0","endTime":"0","summary":"[下跌股]现代中药集团(01643) 股价在下午02:35比前收市价下跌9.211%，现股价为港币$0.345。至目前为止，今日最高价为$0.375，而最低价为$0.345。总成交量为19.2万股，总成交金额为港币$7.065万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2504281116/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01643","BK1606"],"gpt_icon":0},{"id":"2530442478","title":"現代中藥集團盤中異動 股價大跌5.26%報0.360港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530442478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530442478?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 14:34","pubTimestamp":1745822048,"startTime":"0","endTime":"0","summary":"2025年04月28日下午盘14时34分，现代中药集团股票出现异动，股价急速下跌5.26%。截至发稿，该股报0.360港元/股，成交量13.8万股，换手率0.02%，振幅3.95%。资金方面，该股资金流入0港元，流出5.1255万港元。现代中药集团股票所在的中医药行业中，整体跌幅为0.04%。其相关个股中，吉林长龙药业、神威药业、同仁堂科技涨幅较大，振幅较大的相关个股有位元堂、吉林长龙药业、健倍苗苗，振幅分别为13.51%、7.19%、3.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814340897481078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814340897481078&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01643","BK1606"],"gpt_icon":0},{"id":"2530905435","title":"每日賣空追蹤 | 白雲山 04月25日賣空量成交2.4萬股，賣空比例為6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530905435?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 17:12","pubTimestamp":1745572337,"startTime":"0","endTime":"0","summary":"白云山北京时间04月25日，股价较前一交易日持平，卖空量成交2.4万股，较上一交易日增加200%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171626a46696bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171626a46696bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1521","BK1197","BK1515","BK1606","00874"],"gpt_icon":0},{"id":"2530903570","title":"康臣藥業：收到SK-09片臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903570","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530903570?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 17:00","pubTimestamp":1745571654,"startTime":"0","endTime":"0","summary":"格隆汇4月25日丨康臣药业(01681.HK)发布公告，公司已收到中国国家药品监督管理局签发的有关SK-09片的《药物临床试验批准通知书》。SK-09片为一类化学新药。根据披露，足细胞损伤相关肾脏疾病是一类以肾小球足细胞损伤为主要病理改变的肾脏疾病，包括糖尿病肾病、局灶节段性肾小球硬化、微小病变肾病等。患者常因得不到及时有效的治疗，最终进展为终末期肾病(ESRD)，对患者本人、家庭及社会医疗造成沉重负担。目前临床上缺乏针对足细胞保护的靶向疗法，SK-09片的临床研发有望为肾脏病患者提供更为精准有效的治疗新选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042517005494e23a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042517005494e23a18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","03347","BK1191","BK1583","BK1606","BK1141","BK1576"],"gpt_icon":0},{"id":"2530908783","title":"康臣藥業(01681.HK)治療腎臟疾病藥物於中國獲批開展臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2530908783","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530908783?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:48","pubTimestamp":1745570880,"startTime":"0","endTime":"0","summary":"康臣药业(01681.HK) 公布，已收到国家药品监督管理局签发有关“SK-09”片的《药物临床试验批准通知书》。据介绍，相关药物用于足细胞损伤相关肾脏疾病(糖尿病肾病、局灶节段性肾小球硬化及微小病变肾病等)的治疗。(js/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-25 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220720140431349_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220720140431349_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436034/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","BK1606","03347","BK1141","01681","BK1583","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}]}}